These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28058210)

  • 1. Biology of chronic graft-
    Presland RB
    World J Transplant; 2016 Dec; 6(4):608-619. PubMed ID: 28058210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
    Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
    J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD.
    Hayashida JN; Nakamura S; Toyoshima T; Moriyama M; Sasaki M; Kawamura E; Ohyama Y; Kumamaru W; Shirasuna K
    Bone Marrow Transplant; 2013 Jan; 48(1):115-23. PubMed ID: 22659679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic graft-versus-host disease: diagnosis and treatment].
    Inamoto Y
    Rinsho Ketsueki; 2018; 59(5):549-556. PubMed ID: 29877246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
    Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
    J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Fibroinflammatory and Fibrotic Transcriptomic Subsets of Human Cutaneous Sclerotic Chronic Graft-Versus-Host Disease.
    Rosenstein RK; Rose JJ; Brooks SR; Tsai WL; Gadina M; Pavletic SZ; Nagao K; Cowen EW
    JID Innov; 2024 Mar; 4(2):100246. PubMed ID: 38357212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
    Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells.
    Zhang M; Wu Y; Bastian D; Iamsawat S; Chang J; Daenthanasanmak A; Nguyen HD; Schutt S; Dai M; Chen F; Suh WK; Yu XZ
    Front Immunol; 2018; 9():1461. PubMed ID: 29988391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Juric MK; Shevtsov M; Mozes P; Ogonek J; Crossland RE; Dickinson AM; Greinix HT; Holler E; Weissinger EM; Multhoff G
    Front Immunol; 2016; 7():660. PubMed ID: 28138325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.
    Hu R; Liu Y; Su M; Song Y; Rood D; Lai L
    Stem Cells Transl Med; 2017 Jan; 6(1):121-130. PubMed ID: 28170174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral disease profiles in chronic graft versus host disease.
    Bassim CW; Fassil H; Mays JW; Edwards D; Baird K; Steinberg SM; Cowen EW; Naik H; Datiles M; Stratton P; Gress RE; Pavletic SZ
    J Dent Res; 2015 Apr; 94(4):547-54. PubMed ID: 25740857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.
    Reikvam H; Grønningsæter IS; Mosevoll KA; Lindås R; Hatfield K; Bruserud Ø
    Front Immunol; 2017; 8():1979. PubMed ID: 29416533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.
    Forcade E; Paz K; Flynn R; Griesenauer B; Amet T; Li W; Liu L; Bakoyannis G; Jiang D; Chu HW; Lobera M; Yang J; Wilkes DS; Du J; Gartlan K; Hill GR; MacDonald KP; Espada EL; Blanco P; Serody JS; Koreth J; Cutler CS; Antin JH; Soiffer RJ; Ritz J; Paczesny S; Blazar BR
    JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical observation of serum specific biomarkers in patients with chronic graft-versus-host disease].
    Chen T; Li XP; Zhang C; Kong PY; Gao QG; Tang L; Wang R; Yang SJ; Gao L; Liu Y; Gao L; Feng YM; Rao J; Peng XG; Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):948-952. PubMed ID: 31856446
    [No Abstract]   [Full Text] [Related]  

  • 20. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.